Wojciech Naumnik

Bialystok, PD 15540, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Guidelines for Minimizing Bleeding Risk During Bronchoscopic Procedures.

Guidelines for Minimizing Bleeding Risk During Bronchoscopic Procedures.

Journal: Advances in respiratory medicine

Published: May 14, 2026

Translating tumor epigenetic subtyping into methylome network-based prognostic models in early-stage NSCLC: results from the prospective MOBIT study.

Translating tumor epigenetic subtyping into methylome network-based prognostic models in early-stage NSCLC: results from the prospective MOBIT study.

Journal: Journal of translational medicine

Published: November 03, 2025

First insight about the ability of specific glycerophospholipids to discriminate non-small cell lung cancer subtypes.

First insight about the ability of specific glycerophospholipids to discriminate non-small cell lung cancer subtypes.

Journal: Frontiers in molecular biosciences

Published: January 31, 2024

Serum Insights: Leveraging the Power of miRNA Profiling as an Early Diagnostic Tool for Non-Small Cell Lung Cancer.

Serum Insights: Leveraging the Power of miRNA Profiling as an Early Diagnostic Tool for Non-Small Cell Lung Cancer.

Journal: Cancers

Published: August 02, 2023

Applied Molecular-Based Quality Control of Biobanked Samples for Multi-Omics Approach.

Applied Molecular-Based Quality Control of Biobanked Samples for Multi-Omics Approach.

Journal: Cancers

Published: June 20, 2023

Neutrophil/Lymphocyte Ratio (NLR) and Lymphocyte/Monocyte Ratio (LMR) - Risk of Death Inflammatory Biomarkers in Patients with COVID-19.

Neutrophil/Lymphocyte Ratio (NLR) and Lymphocyte/Monocyte Ratio (LMR) - Risk of Death Inflammatory Biomarkers in Patients with COVID-19.

Journal: Journal of inflammation research

Published: March 06, 2023

The Diagnostic Value of Inflammatory Markers (CRP, IL6, CRP/IL6, CRP/L, LCR) for Assessing the Severity of COVID-19 Symptoms Based on the MEWS and Predicting the Risk of Mortality.

The Diagnostic Value of Inflammatory Markers (CRP, IL6, CRP/IL6, CRP/L, LCR) for Assessing the Severity of COVID-19 Symptoms Based on the MEWS and Predicting the Risk of Mortality.

Journal: Journal of inflammation research

Published: February 16, 2023

Efficacy of oral amantadine among patients hospitalised with COVID-19: A randomised, double-blind, placebo-controlled, multicentre study.

Efficacy of oral amantadine among patients hospitalised with COVID-19: A randomised, double-blind, placebo-controlled, multicentre study.

Journal: Respiratory medicine

Published: November 25, 2022

Recommendations for COPD management in Central and Eastern Europe.

Recommendations for COPD management in Central and Eastern Europe.

Journal: Expert review of respiratory medicine

Published: January 10, 2022

The Ability of Metabolomics to Discriminate Non-Small-Cell Lung Cancer Subtypes Depends on the Stage of the Disease and the Type of Material Studied.

The Ability of Metabolomics to Discriminate Non-Small-Cell Lung Cancer Subtypes Depends on the Stage of the Disease and the Type of Material Studied.

Journal: Cancers

Published: May 20, 2021

B Cell-Attracting Chemokine-1 and Progranulin in Bronchoalveolar Lavage Fluid of Patients with Advanced Non-small Cell Lung Cancer: New Prognostic Factors.

B Cell-Attracting Chemokine-1 and Progranulin in Bronchoalveolar Lavage Fluid of Patients with Advanced Non-small Cell Lung Cancer: New Prognostic Factors.

Journal: Advances in experimental medicine and biology

Published: October 26, 2018

Prognostic Value of Osteoprotegerin and sRANKL in Bronchoalveolar Lavage Fluid of Patients with Advanced Non-small Cell Lung Cancer.

Prognostic Value of Osteoprotegerin and sRANKL in Bronchoalveolar Lavage Fluid of Patients with Advanced Non-small Cell Lung Cancer.

Journal: Advances in experimental medicine and biology

Published: October 21, 2017

Showing 1-12 of 28

Last Updated: 09/26/2026